The 30-year U.S. Treasury yield climbed to 5.33% this week, its highest level since 2007, as investors demanded more compensation for a wave of long-dated government bond issuance and inflation that has sat above the Fed’s target for five straight years. For long-term investors, that single number quietly reshapes the competitive landscape for every income stock in the portfolio: a “risk-free” 30-year bond now yields more than most blue-chip dividend payers, and more than the earnings yield on a good chunk of the S&P 500.

The mechanics matter more than the headline number. Rising long-term rates compress the present value of future cash flows — the core input in any discounted cash flow model — which is why growth stocks with earnings years out typically feel more pain than mature dividend payers with cash today. But it is not a free pass for income stocks either. When a 30-year Treasury pays north of 5% with essentially no credit or business risk, a stock yielding 3-4% has to justify itself through dividend growth, not just current yield. Utilities and REITs, the classic “bond proxies,” are the most exposed here. Companies with real pricing power and a multi-decade history of raising payouts are better insulated, because their dividends grow with or ahead of inflation rather than sitting still while the bond market reprices around them.

The broader signal is fiscal, not just monetary. Germany’s own 30-year bond yield hit its highest level since 2011 in the same week, and Japan’s 30-year yield touched a record high — evidence this isn’t a US-only story about tariffs or Fed policy. It’s a global reassessment of how much governments can borrow before bond investors demand a bigger premium for the risk. So what for long-term investors: rising term premiums are a genuine headwind for valuation multiples across the board, but they also reward the specific businesses that keep compounding dividends faster than the bond market is repricing risk. In an environment like this, portfolio composition matters more than any single trade — owning price-setters with durable moats beats owning price-takers that quietly become bond substitutes the moment rates rise.

Colgate-Palmolive just quietly extended a dividend streak that outlasts nearly every business on earth: 63 consecutive years of increases, with uninterrupted payouts stretching back to 1895. That’s not a typo — investors buying the stock today are collecting checks from a company that was paying dividends before the Wright brothers flew. For patient, income-focused investors, that kind of institutional durability is worth far more attention than it currently gets.

The numbers behind the streak are what make it credible rather than merely nostalgic. Second-quarter net sales rose 4.9% to $5.36 billion, and Base Business earnings per share climbed 8% to $0.99, with gross margin expanding 140 basis points to 61.5%. More importantly for dividend sustainability: operating cash flow hit $1.74 billion in the first half of 2026, up from $1.48 billion a year earlier, while the company paid out $879 million in dividends over the same stretch. Free cash flow covered the payout with room to spare — the single most important metric for anyone betting on a dividend lasting another decade, let alone another century.

Colgate’s moat is unglamorous but effective: 41.3% global toothpaste market share and 32.7% of the manual toothbrush market, built on products people buy on autopilot regardless of economic conditions. Organic sales growth of just 2.4% (and a 3% decline in North America) explains why the stock doesn’t excite growth investors — there’s no AI angle, no re-rating story, no double-digit yield to chase. Management held its 2026 outlook steady at mid-single-digit Base Business EPS growth, hardly headline material.

So what for long-term investors: this is precisely the kind of “boring” compounder that gets ignored while capital chases flashier names, yet it’s the type of holding that quietly does the heavy lifting in a diversified portfolio over 20-30 year horizons. A 63-year dividend growth streak isn’t luck — it reflects pricing power, brand loyalty, and disciplined capital allocation that survive recessions, pandemics, and management changes alike. Investors focused on total return rather than this quarter’s growth rate may find more value in Colgate’s consistency than in whatever is dominating headlines this week.

For 14 consecutive quarters, Berkshire Hathaway sold more stock than it bought — a stretch of institutional patience that outlasted even Warren Buffett’s famously long timeline. That streak just broke. In Q2, under new CEO Greg Abel, Berkshire became a net buyer for the first time since 2022, purchasing roughly $23.5 billion in shares against $3.7 billion sold, a net swing of about $20 billion. The long-term signal here matters more than the headline earnings beat: Berkshire’s capital allocation engine, dormant since Buffett began stepping back, is running again.

The numbers underneath tell a disciplined story, not a reckless one. Operating earnings rose 16% year-over-year to $12.98 billion, while net earnings more than doubled to $25.67 billion, boosted by $12.68 billion in investment gains. Buybacks jumped from a token $235 million in Q1 to $4.5 billion in Q2, with another $3.3 billion repurchased in July alone. Roughly $21 billion of the new buying went into commercial and industrial names, alongside a fresh $6.8 billion all-cash acquisition of homebuilder Taylor Morrison — a bet on U.S. housing that plays out over years, not quarters. Even after this spending, Berkshire’s cash and Treasury position sits at $365.5 billion, down modestly from a record $397.4 billion but still the largest dry-powder reserve of any public company on earth.

What makes this notable isn’t the size of the checks — it’s the pattern. Abel, now a full two quarters into the job, appears to be applying the same discipline Buffett preached for six decades: hoard cash when prices are unattractive, deploy decisively when they aren’t. Hedge fund ownership of Berkshire dipped slightly during the leadership transition (133 funds to 126), a modest wobble rather than a vote of no confidence, especially with short interest sitting at a negligible 0.92%.

So what for long-term investors: the reopening of Berkshire’s capital spigot is a tell about where a famously patient, valuation-sensitive allocator sees value right now — industrials, commercial names, and U.S. housing exposure — while still keeping over a third of a trillion dollars in reserve for the next real dislocation. For investors trying to gauge whether markets are overheated or merely fully priced, Abel’s willingness to spend, rather than his rhetoric, is the more reliable signal to watch.

Corporate America just posted its most profitable quarter in at least 17 years — and the details matter more than the headline. The S&P 500’s net profit margin hit 16.9% in the second quarter, according to FactSet data, the highest reading since the firm began tracking the metric in 2009. That’s up sharply from 14.8% in the first quarter and 12.9% a year ago, and well above the five-year average of 12.4%. For long-term investors, the real question isn’t whether margins are rising — it’s whether this kind of profitability is durable or borrowed from a couple of unusual sources.

Two names explain an outsized share of the jump. Alphabet posted a 34% operating margin, up from 32% a year earlier, and booked a $98 billion gain in other income — mostly unrealized paper gains on equity stakes, not cash from operations. Amazon logged $53.4 billion in other income, largely tied to its investment in Anthropic, while its own operating margin rose to 13.7% from 11.4%. Strip both companies out and the S&P 500’s margin still lands at 15%, itself a record dating back to 2009 — so the strength is real and broad, not just a mega-cap illusion. Eight of the index’s 11 sectors improved margins year-over-year, led by technology, communication services, consumer discretionary, and energy.

Vanguard senior economist Adam Schickling frames it simply: "Businesses, when they’re busy, are more profitable. Firms are busier, they’re more efficient, and that translates into higher margins." Tech’s asset-light model — adding customers without proportional cost increases — remains the structural edge behind sector-leading profitability. But Schickling also flags rising competitive pressure from new entrants as a risk to that edge going forward, a reminder that today’s moat can narrow.

So what for long-term investors: margin expansion is a legitimate signal of quality and pricing power, but the 2026 number is flattered by paper gains that could reverse with market swings. Before paying up for record profitability, separate durable operating margin from one-time investment gains, and watch whether competitive intensity in tech — where most of the improvement is concentrated — starts compressing the very edge that produced it.

SK Hynix just committed $720 billion to build what it calls the largest network of memory factories on Earth, and the bet is simple: the AI boom’s real bottleneck isn’t chips, it’s the memory that feeds them. The South Korean company controls 58% of the high-bandwidth memory market that powers every major AI processor, more than double the share held by rivals Samsung or Micron. That’s the kind of structural dominance long-term investors should notice, even as the stock has skidded 21% from its July highs.

The numbers behind the buildout are staggering. SK Hynix raised $26.5 billion in July through a Nasdaq listing, the largest capital raise ever by a foreign company on U.S. markets, and it’s plowing the proceeds into fabs so tall they’ll rival 50-story buildings. Nvidia has already signed a $500 billion deal for guaranteed supply and co-development of next-generation memory, and SK Group’s chairman says “if you name any company in Big Tech, they are all in Korea to sign a contract.” Demand from Microsoft, Google, Meta, and Amazon isn’t speculative chatter, it’s contracted, multi-year revenue.

What makes this more than a cyclical chip story is the shift toward custom HBM, memory co-designed directly with AI processors rather than sold as an interchangeable commodity. That’s a moat-widening development: pricing power increases when your product is engineered into a customer’s chip roadmap years in advance, not swapped out when the next price war hits. It’s also why South Korea’s president is pushing to double the country’s memory output within five years, and why Micron is racing to match SK Hynix with $150 billion in new U.S. fabs of its own.

The recent pullback reflects broader AI-trade jitters, not a crack in SK Hynix’s underlying position. A company that just tripled its market cap to over $1 trillion, locked in a decade of demand from the biggest AI spenders in the world, and is transitioning from commodity supplier to indispensable co-engineer isn’t a business getting weaker because the stock dipped 21%. So what for long-term investors: when a dominant, moat-building supplier to an entire industry goes on sale during a sector-wide wobble, that’s usually the setup, not the warning sign.

Aviva shares have climbed roughly 150% since Amanda Blanc took the helm in July 2020 — a rare feat for a UK insurer that burned through four CEOs in the previous 13 years. The turnaround is done. What matters now for long-term investors is the next chapter: a pivot from balance-sheet repair to a genuine growth engine in UK wealth management, a market Aviva pegs at £2.7 trillion today and projects will top £4 trillion by 2030.

Blanc’s playbook was disciplined capital allocation, not financial engineering. She raised roughly £8 billion selling eight non-core businesses — exiting France, Italy, and Poland — and returned about £10 billion to shareholders via dividends and buybacks while narrowing Aviva to three core markets: UK, Canada, and Ireland. She then redeployed capital into scale, buying rival Direct Line for £3.7 billion in December 2024 (now a fifth of UK motor insurance) and Succession Wealth for £385 million in 2022, the seed of a wealth unit expected to reach 10% of group earnings. Half-year results due this Friday are expected to show operating profit up 17.5% year-over-year to roughly £1.3 billion.

The risks are real: some Aviva Investors funds show patchy performance, autonomous vehicles pose a long-run structural threat to motor insurance premiums, and the broadened business mix invites comparison to lower-multiple European composites like Allianz and Axa rather than a premium UK life insurer. But the underlying moat is hard to replicate — nearly 22 million UK customers, the second-largest customer base of any bank or insurer in the country, and 500,000 retail shareholders who’ve stuck around since the Norwich Union days. So what for long-term investors: a management team with a proven record of turning divestiture proceeds into disciplined, accretive acquisitions is now aiming that same capital discipline at a structurally growing wealth market — the kind of compounding setup patient dividend investors should be watching closely into Friday’s numbers.

Baker Hughes just posted its best quarter in years, and the headline numbers tell a story that oil bulls and skeptics will both want to claim. Shares jumped more than 6% after second-quarter earnings per share came in at 64 cents, crushing the 50-cent consensus estimate, according to LSEG data. But the real signal for patient investors isn’t the beat — it’s where the growth is actually coming from.

Orders surged 49% year-over-year to a record $10.5 billion, and $7.1 billion of that came from the company’s Industrial and Energy Technology segment — the division serving LNG export terminals, power grids, and data centers, not oil rigs. Backlog climbed 19% to an all-time high, with $40.1 billion in contracted work now on the books. CEO Lorenzo Simonelli has been reframing Baker Hughes around what he calls a “demand decade for energy,” pushing the 100-plus-year-old oilfield services company deeper into the infrastructure that powers AI data centers and electrified grids rather than just wells and pipelines.

That pivot matters because the old business is softening. Baker Hughes itself said global oil and gas producer spending will decline modestly this year, as weakness in Europe and the Middle East — exacerbated by the ongoing U.S.-Iran standoff — offsets gains in Latin America and North America. Third-quarter revenue guidance for the IET segment, $3.17 billion to $3.47 billion, actually falls short of the $3.79 billion Wall Street wanted, and management flagged 1-2 points of Middle East-related drag plus rising logistics costs. This isn’t a company pretending everything is fine; it’s one candidly showing two divergent stories in the same earnings report.

Hedge funds appear to be underwriting the pivot ahead of the retail crowd. Insider Monkey’s database shows Baker Hughes had 72 hedge fund holders as of Q1 2026, up sharply from 59 the prior quarter, with dollar exposure roughly doubling from $797 million to $1.62 billion — before this earnings beat even hit the tape. That puts Baker Hughes on par with oilfield peers Halliburton (72 holders, up from 53) and SLB (74, up from 73), suggesting smart money sees the whole sector’s infrastructure angle re-rating, not just one name.

So what for long-term investors: a $40.1 billion backlog and a 19% jump in contracted work is the kind of visibility that lets a company weather a cyclical energy downturn without cutting the dividend or capex that builds the next decade’s moat. Baker Hughes trades as an oilfield services stock, but an increasing share of its economics now looks more like an industrial infrastructure company riding the same LNG and power buildout tailwinds as utilities and grid-equipment makers. The near-term guidance miss is real, but for investors who care about where backlog and order growth are heading over three to five years rather than the next quarter, this looks less like an oil stock in decline and more like an energy-transition compounder that hasn’t been repriced yet.

Oracle shares are down 26% this year, yet the company’s forward-looking numbers tell a starkly different story than the stock price suggests. Its Remaining Performance Obligations — contracted revenue not yet recognized — hit a record $638 billion in the most recent quarter, while cloud revenue grew 47% year-over-year and Infrastructure-as-a-Service nearly doubled, up 93%. For patient investors, that gap between sentiment and substance is exactly the kind of setup worth studying.

The market’s skepticism centers on Oracle’s aggressive AI capital spending, with capex running near $35 billion this year to build out data center capacity. Wall Street has punished the stock for the spend, treating it as a drag rather than an investment. But Mizuho analyst Siti Panigrahi, who added Oracle to the firm’s August top-picks list, argues the buildout is the fuel for a structural inflection: he projects 34% operating income compound annual growth through fiscal 2030, more than ten times the 3% CAGR Oracle delivered between 2010 and 2020. That’s not incremental improvement — it’s a business model shift, powered by database, infrastructure, and application layers all monetizing the same AI wave simultaneously.

What makes this interesting for value-oriented investors isn’t just the growth math — it’s the valuation mismatch it creates. A company compounding operating income at more than 10x its historical rate, with backlog visibility stretching years into the future, is trading at a discount most investors reserve for businesses in decline, not businesses accelerating. Oracle’s transformation from a legacy database vendor into critical AI infrastructure plumbing — sitting underneath enterprise workloads that are expensive and disruptive to migrate away from — is exactly the kind of durable, moat-widening shift long-term holders should want to own before consensus catches up.

So what for long-term investors: backlog conversion, not quarterly headlines, is the metric to track here. If Oracle converts even a fraction of that $638 billion RPO into recognized revenue at improving margins over the next several years, today’s 26% drawdown may look, in hindsight, like the entry point patient capital was waiting for.

Berkshire Hathaway just gave long-term investors the clearest signal yet that its capital-allocation drought is over. In its first full quarter under new CEO Greg Abel, the conglomerate repurchased roughly $4.5 billion of its own stock — a sharp jump from just $235 million in the first quarter — and became a net buyer of equities for the first time in 14 consecutive quarters, adding nearly $20 billion in net stock purchases. For a company that had been quietly hoarding cash while Warren Buffett said he couldn’t find value, that reversal matters more than the headline earnings print.

The underlying businesses did their part too. Operating earnings — the metric Buffett and Abel have long called the truer read on Berkshire’s health — rose 16% to $12.98 billion from $11.16 billion a year earlier. Manufacturing, service and retailing earnings jumped 24% to $4.47 billion, Berkshire Hathaway Energy’s profit surged 27% to $891 million, and BNSF’s railroad income climbed 6% to $1.56 billion. Insurance was the soft spot, with underwriting income down 13% to $1.73 billion and investment income off 9% to $3.06 billion — a reminder that even Berkshire’s steadiest moat has cyclical dents.

Berkshire’s fabled cash pile, which peaked near $397 billion last quarter, fell to about $365.5 billion as Abel funded buybacks, the $8.5 billion Taylor Morrison acquisition, and fresh equity stakes. Alphabet has now climbed into Berkshire’s top five holdings by market value, joining long-standing anchors American Express, Apple, Bank of America and Coca-Cola — a notable shift for a portfolio that avoided Big Tech for decades.

Berkshire shares are up just 3% this year, trailing the S&P 500’s 13% gain, even after a 9% rally over the past three months. That gap is the real story: a company sitting on diversified, cash-generating businesses and a newly aggressive buyback program is being priced like it’s standing still. So what for long-term investors — Berkshire’s discount to the broader market, paired with a management team finally willing to deploy capital rather than just stockpile it, is exactly the kind of quiet mismatch patient shareholders have historically been rewarded for holding through.

Otis Worldwide’s stock is down roughly 15% year-to-date, but the business generating over 90% of its profits — servicing the 2.5 million elevators it already has in the field — just got structurally more valuable. In April, Finland’s Kone agreed to buy Germany’s TK Elevator for nearly $35 billion, a deal that would shrink the industry from four major players to three. If it clears regulatory scrutiny, Otis inherits a more rational, less price-competitive market for the recurring service contracts that actually make it money.

That’s the part Wall Street’s AI-chasing capital seems to be missing. Otis’s new-equipment business — installing elevators — runs at a thin 4.8% operating margin; nobody gets rich building elevators. The real engine is the 20-year-plus service tail that follows each installation: maintenance, repairs, and eventual modernization, which together produced a 25.5% margin in 2025. The company services elevators in more than 200 countries and grew service sales 11% year-over-year in its most recent quarter, even as retention — the renewal rate on those contracts — hasn’t yet fully recovered from a slump that started in 2025. Otis is plowing an incremental $50 million into fixing that in 2026, betting that fewer outages mean happier, stickier customers. Renewals are somewhat automatic if no one is unhappy, as one analyst put it.

None of this is glamorous. There is no AI angle, no chip shortage narrative, no 40% quarterly revenue growth. What Otis offers instead is what patient capital has always prized: a toll-booth business with decadeslong tailwinds from urbanization, an aging population needing mobility solutions, and infrastructure modernization that is not going away regardless of what happens with data center capex. Management describes this as a decadelong opportunity, not a quarterly trade.

So what for long-term investors: a 15% pullback in a company where roughly 90 cents of every profit dollar comes from recurring, multi-decade service contracts — with a looming industry consolidation that could reduce competitive intensity — is exactly the kind of boring-is-beautiful mispricing patient capital should be watching. The retention numbers over the next two quarters will tell you whether the moat is widening or just holding steady.